The PRECISE Trial: Study of IL13-PE38QQR Compared to GLIADEL Wafer in Patients With Recurrent Glioblastoma Multiforme
Status:
Completed
Trial end date:
2007-03-01
Target enrollment:
Participant gender:
Summary
The purpose of the PRECISE trial is to determine whether overall survival duration, safety,
and quality of life are improved for patients treated with IL13-PE38QQR compared to patients
treated with GLIADEL® Wafer following surgical tumor removal in the treatment of first
recurrence of glioblastoma multiforme.